Legend Biotech (LEGN) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$278.9 million.
- Legend Biotech's Enterprise Value rose 3927.56% to -$278.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$278.9 million, marking a year-over-year increase of 3927.56%. This contributed to the annual value of -$1.3 billion for FY2024, which is 4.64% up from last year.
- As of Q3 2025, Legend Biotech's Enterprise Value stood at -$278.9 million, which was up 3927.56% from -$266.7 million recorded in Q2 2025.
- Legend Biotech's Enterprise Value's 5-year high stood at -$243.5 million during Q2 2024, with a 5-year trough of -$1.4 billion in Q2 2023.
- Its 5-year average for Enterprise Value is -$666.3 million, with a median of -$459.3 million in 2024.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 44662.56% in 2021, then surged by 8284.29% in 2024.
- Quarter analysis of 5 years shows Legend Biotech's Enterprise Value stood at -$690.4 million in 2021, then crashed by 40.74% to -$971.6 million in 2022, then tumbled by 31.57% to -$1.3 billion in 2023, then skyrocketed by 77.56% to -$286.8 million in 2024, then increased by 2.76% to -$278.9 million in 2025.
- Its Enterprise Value was -$278.9 million in Q3 2025, compared to -$266.7 million in Q2 2025 and -$441.8 million in Q1 2025.